Female Sexual Dysfunction: A Case Study of Disease Mongering and Activist Resistance
Open Access
- 11 April 2006
- journal article
- review article
- Published by Public Library of Science (PLoS) in PLoS Medicine
- Vol. 3 (4), e178
- https://doi.org/10.1371/journal.pmed.0030178
Abstract
Tiefer highlights key steps in the "creation" of a new diagnosis, female sexual dysfunction, and of the campaign to challenge its reductionist approach to women's sexual problems.Keywords
This publication has 13 references indexed in Scilit:
- Bigger and Better: How Pfizer Redefined Erectile DysfunctionPLoS Medicine, 2006
- Omissions, biases, and nondisclosed conflicts of interest: is there a hidden agenda in the NAMS position statement?2005
- The role of testosterone therapy in postmenopausal women: position statement of The North American Menopause SocietyMenopause, 2005
- Inaugural Supplement of The Journal of Sexual Medicine on Women's Sexual Health Concerns: Postmenopausal Female Sexual Dysfunction RoundtableThe Journal of Sexual Medicine, 2005
- Public Health Advocacy to Change Corporate Practices: Implications for Health Education Practice and ResearchHealth Education & Behavior, 2005
- The marketing of a disease: female sexual dysfunctionBMJ, 2005
- Pfizer will not apply for a licence for sildenafil for womenBMJ, 2004
- A New Non-Pharmacological Vacuum Therapy for Female Sexual DysfunctionJournal of Sex & Marital Therapy, 2001
- Sexual Dysfunction in the United StatesJAMA, 1999
- Vasculogenic female sexual dysfunction: The hemodynamic basis for vaginal engorgement insufficiency and clitoral erectile insufficiencyInternational Journal Of Impotence Research, 1997